Psychedelics Reform Update: AZ Budget Includes Psilocybin Research,…
A faster one To update on the status of the state-level psychedelics bills discussed on May 12: Arizona: Gov. Katie Hobbs (D) approved
May 14, 2023
A faster one To update on the status of the state-level psychedelics bills discussed on May 12: Arizona: Gov. Katie Hobbs (D) approved
cannabis company Creso Pharma COPHF‘s wholly owned Psychedelics subsidiary Halucenex Life Sciences Inc. shared promising early insights into its progress Phase 2 clinical study Evaluating
The results of an advanced clinical trial evaluating psilocybin-assisted therapy for patients with cancer and major depressive disorder (MDD), conducted by Sunstone Therapies Oncology Center,
biopharmaceutical company Apex Labs Ltd. completed one of the first clinical trials of take-away microdoses of psilocybin and met all study endpoints over a two-month
United Food and Commercial Workers (UFCW) Local 360 recently announced that it publicly supports New Jersey Assembly Bill A4911, which authorizes the production and use
When inventors need an NDA, what it actually protects, and the routine confidentiality habits that keep patent options open before filing.
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind